Oncology Clinical Scientist — Hybrid/Remote Leader

Sotalent; Cambridge (MA); Hybrid; USD 116,000 - 182,000; Full time

Benefits offered by this job

Comprehensive benefits

Hybrid work model

Diversity and inclusion culture

Job summary

Sotalent in Cambridge, MA is seeking a Clinical Scientist to lead oncology development within a global pharmaceutical context. The role blends scientific leadership with cross-regional collaboration to shape development plans and regulatory strategies.

You will drive study design, partner with medical monitors and regulators, and defend proposals to review committees, while guiding teams across the US and Europe under a hybrid work model.

Qualifications

• Bachelor degree with 6 years of experience, Master 4 years, PharmD 2 years, or PhD 1 year.
• Experience in clinical research or development within pharma, CRO, academic, or healthcare consulting.
• Strong understanding of GCP and ICH guidelines and regulatory requirements.
• Deep oncology knowledge and ability to drive decisions in multi-regional teams.

Responsibilities

• Serve as a scientific lead for development teams in US and Europe.
• Author clinical protocols, study synopses, and development plans.
• Monitor trial data and provide go/no-go recommendations.
• Present and defend study designs before review committees.
• Collaborate with medical monitors and pharmacovigilance for patient safety.
• Liaise with key opinion leaders and regulatory agencies to influence strategy.
• Contribute to internal task forces with market insights by therapeutic area.

Skills

Communication skills

Negotiation skills

Education

Bachelor degree with experience

Master degree with experience

PharmD with experience

PhD with experience

Job description

Sotalent in Cambridge, MA is seeking a Clinical Scientist to lead oncology development within a global pharmaceutical context. The role blends scientific leadership with cross-regional collaboration to shape development plans and regulatory strategies.

You will drive study design, partner with medical monitors and regulators, and defend proposals to review committees, while guiding teams across the US and Europe under a hybrid work model.